Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. - Wikidata - wikimedia - TriplyDB

Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.

Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.

http://www.wikidata.org/entity/Q47354614

about

Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants Antifungal therapy for newborn infants with invasive fungal infection Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants Central venous catheter (CVC) removal for patients of all ages with candidaemia Prenatal Alcohol Exposure and the Developing Immune System The epidemiology and diagnosis of invasive candidiasis among premature infants Fluconazole prophylaxis for prevention of invasive candidiasis in infants Treatment and prophylaxis of invasive candidiasis Neonatal candidiasis: diagnosis, prevention, and treatment Fluconazole pharmacokinetics and safety in premature infants Advances in the treatment of invasive neonatal candidiasis Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis Prevention and treatment of neonatal nosocomial infections.Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data.Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial.Changes in the incidence of candidiasis in neonatal intensive care units.Safety and pharmacokinetics of repeat-dose micafungin in young infants.Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants Pharmacokinetics of an elevated dosage of micafungin in premature neonates.Population pharmacokinetics of fluconazole in young infants.Human endothelial cells internalize Candida parapsilosis via N-WASP-mediated endocytosis Prediction of micafungin area under the curve data by using peak concentration: applicability and utility in antifungal therapy.Clinical and laboratory factors that predict death in very low birth weight infants presenting with late-onset sepsis.Performance of a Quantitative PCR-Based Assay and Beta-D-Glucan Detection for the Diagnosis of Invasive Candidiasis in Very Low Birth Weight Preterm Neonatal Patients (CANDINEO Study).Deletion of Candida albicans SPT6 is not lethal but results in defective hyphal growth.Early and late onset sepsis in late preterm infants.Epidemiology of Candida albicans and non-C.albicans of neonatal candidemia at a tertiary care hospital in western China Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection Medication use in the neonatal intensive care unit Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls.High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.Recent Advances in the Detection of Neonatal Candidiasis Investigation of OCH1 in the Virulence of Candida parapsilosis Using a New Neonatal Mouse Model.Population pharmacokinetics of micafungin in neonates and young infants Primary immunodeficiencies underlying fungal infections

P2860

Q24186382-3031D24C-EB6D-4403-93A9-B5D9B2674867 Q24186385-52AD4E29-0A9A-4AD0-8833-92BC4A3F6BBC Q24197610-BE73E9F1-E894-4AD1-9D7C-D56D4C6C177D Q24200229-1805ABA7-225B-4F12-B7AA-04F3C6BDD759 Q24202811-226CA57F-981D-446A-899B-4721824E3C42 Q24240112-27A3AF0F-E16D-4F2E-A903-97EDEB749C7A Q24243140-F8EA5D11-EC69-4854-9BCD-BA81EE558E75 Q26471135-55E3B575-4CF1-4449-89B5-02CD02361E0E Q26773220-07A1E98A-9796-4445-BCEF-1DB3B41E6F87 Q26861652-25D475DB-4B58-4E12-AC99-1C473D22821C Q26995413-C421F811-8ED8-4FA8-86F5-96A9FA11ACDA Q27001567-82490CD8-8CCC-4BC9-9A51-138FAF8642CC Q27008471-4EF52927-FEA9-4B61-B7E2-F1ECCA0A15AB Q27014816-767B946F-9D2B-41C7-9178-8A68B537FA07 Q27022585-4DC7DFCA-3306-42FB-95C2-AD7767519128 Q27025299-822CD049-F1C4-477B-B7AC-E7440AFFD0A5 Q28533912-0379A4F5-046D-4AF2-B6F8-8DD7B8D64B34 Q30235610-54EBCE25-27A9-446E-B2B4-52C2B31BA9D6 Q30276620-814AD3EE-0AF3-475F-9145-DC7ABB9F90CD Q30405312-976F7779-0C89-4756-8FEC-B750C0B73696 Q30408409-D79B3986-7879-4766-B297-652226FA5C3E Q30433612-875782C6-D7A9-4745-B2C3-9151BB4579D7 Q30435365-67ED3222-55ED-4D0E-B34A-76DFAA861837 Q30436332-2550C7F5-7F8A-4AE3-A637-30A2020517D6 Q30439710-59C3D32A-29F1-4594-99E9-0CDDDDE608FF Q30541724-96B2D8DB-2648-4D1C-9A03-3D8919D694F4 Q31075176-C06DD56E-A7EC-4D5F-AE2D-08391656C80F Q33412631-1558AC8E-A0DD-4B9C-BA4B-6D6E7E7D7CFE Q33443072-21B369A3-1AE2-4FC8-A164-6D62C1F183FE Q33522845-2616AA4B-7EE3-48C7-875A-A90642A289C0 Q33559246-1ECEE710-0620-456C-B533-C932DA2FA447 Q33644932-4DE0FECF-DFFF-4589-91F6-E8D7463A88F2 Q33693432-D7D52524-64F0-4FCD-ACBB-F9DDEC1D52A6 Q33769958-26A02E47-A194-45D2-B719-2A9F6BC2E583 Q33777640-B685F40A-89D0-47FE-8368-AA153693B056 Q33825648-38182718-3522-4907-8340-33BFF3AD879E Q33827715-2A407AF3-43C3-4B8B-A976-B9D6307EAF8A Q33854412-E44B3F10-32EA-4304-9E8F-E39A0187BC26 Q33876608-8A78D7B3-F67D-4372-86CF-78C23A697B15 Q33902831-A08059A4-FC2D-49F2-994C-F10DC5EB0396

P2860

Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.

http://www.wikidata.org/entity/Q47354614

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Neonatal candidiasis among ext ...... l outcomes at 18 to 22 months.

@en

Neonatal candidiasis among ext ...... l outcomes at 18 to 22 months.

@nl

type

label

Neonatal candidiasis among ext ...... l outcomes at 18 to 22 months.

@en

Neonatal candidiasis among ext ...... l outcomes at 18 to 22 months.

@nl

prefLabel

Neonatal candidiasis among ext ...... l outcomes at 18 to 22 months.

@en

Neonatal candidiasis among ext ...... l outcomes at 18 to 22 months.

@nl

P1433

Q47354614-52047AE7-30A3-4E67-A8A9-5713BED268B4

P1476

Q47354614-6BBD1D7A-910E-43CE-951F-5DF4A625922A

P2093

Q47354614-06EA61BD-94C9-45B1-BAEA-E8E81154FF16

Q47354614-19CB1BE0-2B18-4541-B708-1F14132130CE

Q47354614-23545C13-C502-424A-B7B8-622446DAA4C6

Q47354614-5D08A200-7EB8-4A74-AFAF-B5652E3BC276

Q47354614-9D7ABB43-E951-4848-B234-30F0DF3C7548

Q47354614-C8014510-DBBA-48B1-B66F-BB23406A2D94

Q47354614-E1C7AE4E-38FB-4685-9FE3-406C512835A0

Q47354614-E2F5F76F-5BEC-4860-85D2-25C17B198EB5

Q47354614-EAB0BF08-5A50-463C-BE12-50B99CBF5B25

Q47354614-EBFE20FF-9525-4D95-866C-8AE06932F1BC

P304

Q47354614-7A5E7CCF-7295-4C63-9AB0-10BE37AF8A1C

P31

Q47354614-5AB62A4F-449D-47F7-88B4-50C9190A0EFE

P356

Q47354614-AF6E9ECA-B5A8-411B-8B28-8022294B3A38

P407

Q47354614-5C456450-AAE4-4C7D-9745-15AD5ADA2143

P433

Q47354614-ED57BAE6-EC6A-4328-8A69-9BCE922A0371

P478

Q47354614-8B5FE49B-40DC-4967-BB71-DC0EFF91CD7C

P577

Q47354614-BB6E7710-1AD7-40E7-B648-2D597A89A172

P698

Q47354614-26886616-B6D9-4B54-9E9C-25A84C289001

P921

Q47354614-547AFCD1-917F-4B6A-A21F-3F4F7AE97DC0

Q47354614-DF2A11BF-5343-4DA6-86A1-D6C3B1C292DA

P356

P1433

P1476

Neonatal candidiasis among ext ...... l outcomes at 18 to 22 months.

@en

P2093

Abbot Laptook

http://www.w3.org/2001/XMLSchema#string

Avory A Fanaroff

http://www.w3.org/2001/XMLSchema#string

Barbara J Stoll

http://www.w3.org/2001/XMLSchema#string

Daniel K Benjamin

http://www.w3.org/2001/XMLSchema#string

Kenneth Poole

http://www.w3.org/2001/XMLSchema#string

National Institute of Child Health and Human Development Neonatal Research Network

http://www.w3.org/2001/XMLSchema#string

Ronald Goldberg

http://www.w3.org/2001/XMLSchema#string

Rosemary D Higgins

http://www.w3.org/2001/XMLSchema#string

Scott A McDonald

http://www.w3.org/2001/XMLSchema#string

Shahnaz Duara

http://www.w3.org/2001/XMLSchema#string

P304

84-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2004-2292

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16396864

http://www.w3.org/2001/XMLSchema#string

P921

child mortality